Privacy Policy

Shinfield Pharmaceuticals Limited Online Privacy Policy

Thank you for visiting Shinfield Pharmaceuticals Ltd website or interacting with us via e-mail.

At Shinfield, we are well aware that protecting the privacy of visitors to our Web sites is very important and that information provided by you may be related to your health and therefore is sensitive and confidential. That’s why we have taken the necessary steps to meet worldwide data privacy requirements. We obtain and treat your ‘personal information & confidential data’ with utmost caution according to the laws of the UK, EU, and other applicable local laws which regulate the storage, process, access and transfer of personal data anywhere we work.

Please note that we shall only collect personally identifiable information about you if you choose to give it to us through our “Contact Us Page”. We do not share any of your personally identifiable information with third parties for their own marketing use unless you explicitly give us permission to do so.

Shinfield Pharmaceuticals may obtain information from you by use of “cookies”. These are a small file of letters and numbers that we put on our computer systems with your consent. These can then us how and when pages in a website are visited and by how many people. With the information we aim to improve our sites, although cookies do not normally contain personally identifiable information, if you have provided us with information about yourself, we may associate your registration information with cookies our website may place on your computer’s hard drive. Associating a cookie with your registration information allows us to offer increased personalization and functionality, especially for your next visit, without which this will not happen.

Pharmaceuticals News

Aug 28, 2014 European Medicines Agency Accepts Marketing Authorization Application for Asfotase Alfa as a Treatment for Patients with Hypophosphatasia

European Medicines Agency Accepts Marketing Authorization Application for Asfotase Alfa as a Treatment for Patients with HypophosphatasiaEuropean Medicines Agency Accepts Marketing Authorization Application for Asfotase Alfa as a Treatment for Patien

More News
For General
Enquiries Call Us on + 234 (0) 7020687006